(19)
(11) EP 3 890 830 A2

(12)

(88) Date of publication A3:
23.07.2020

(43) Date of publication:
13.10.2021 Bulletin 2021/41

(21) Application number: 19816630.8

(22) Date of filing: 04.12.2019
(51) International Patent Classification (IPC): 
A61P 9/04(2006.01)
A61K 38/17(2006.01)
 A61P 9/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 9/10; A61P 9/04; A61K 38/17
(86) International application number:
PCT/EP2019/083597
(87) International publication number:
WO 2020/115095 (11.06.2020 Gazette 2020/24)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 05.12.2018 EP 18382897

(71) Applicant: Glycardial Diagnostics, S.L.
08028 Barcelona (ES)

(72) Inventors:
  • BADIMON MAESTRO, Lina
    08025 Barcelona (ES)
  • CUBEDO RÀFOLS, Judit
    08025 Barcelona (ES)
  • VILAHUR GARCÍA, Gemma
    08025 Barcelona (ES)

(74) Representative: ABG Intellectual Property Law, S.L. 
Avenida de Burgos, 16D Edificio Euromor
28036 Madrid
28036 Madrid (ES)

   


(54) METHODS AND COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF ISCHEMIA AND OF ISCHEMIA/REPERFUSION INJURY